Iron-based biomarkers for personalizing pharmacological ascorbate therapy in glioblastoma: insights from a phase 2 clinical trial

ConclusionsThis study analyzes iron-related biomarkers in the context of P-AscH− therapy for glioblastoma. Integrating molecular, systemic, and imaging-based markers offers a multifaceted approach to tailoring treatment strategies, thereby contributing to improved patient outcomes and advancing the field of glioblastoma therapy.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research